3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Leukemia, Promyelocytic, Acute
20
Leukemia, Myeloid, Acute
20
Myelodysplastic Syndromes
9
Multiple Myeloma
9
Leukemia
8
Pancreatic Neoplasms
4
Neoplasm Metastasis
4
Uterine Cervical Neoplasms
3
Neuroblastoma
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Thrombocytopenia
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pathologic Complete Response
2
Neoplasms, Plasma Cell
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Melanoma
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Congenital Abnormalities
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Blast Crisis
2
Interventions
ribociclib
1
Tretinoin
1
Letrozole
1
Goserelin
1
Drug Therapy
1
Chemotherapy, Adjuvant
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
HER2 Negative Breast Cancer
×
Tretinoin
×
Clear all
NCT06731140
2025-11-17
Resilire
Fudan University
Phase 2
Recruiting
10 enrolled